Enlimomab is a mouse monoclonal antibody against ICAM-1 and has been observed to inhibit neutrophil adhesion to brain endothelium in vitro. Enlimomab is proved to be beneficial in reducing disease activity in a subset of patients with rheumatoid arthritis.